Clinical Trials for Nonalcoholic Steatohepatitis (NASH)

Find clinical trials for nonalcoholic steatohepatitis (nash). Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

NCT ID: NCT06947304

This clinical trial is studying a new treatment called Miricorilant to see how it affects liver fat in patients with a condition known as Metabolic Dysfunction-Associated Steatohepatitis (MASH), wh...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Columbia, Missouri, United States

To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

NCT ID: NCT06216041

This clinical trial is studying a new medication called IMM-H014 to see how safe it is and how well it works in people with a liver condition known as nonalcoholic steatohepatitis (NASH). The trial...

Recruiting

Phase: PHASE1 Type: interventional Locations: Changchun, Jilin, China

Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis

NCT ID: NCT03572465

This clinical trial is studying new ultrasound techniques to diagnose a liver condition called nonalcoholic steatohepatitis (NASH), which is a more serious form of nonalcoholic fatty liver disease ...

Recruiting

Type: observational Locations: Montréal, Quebec, Canada

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

NCT ID: NCT06108219

The MONARCH trial is a research study looking at a new treatment called Miricorilant for adults with Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH). ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hialeah Gardens, Florida, United States, Chandler, Arizona, United States +45 more

Study of ADI-PEG 20 Versus Placebo in Subjects With NASH

NCT ID: NCT05842512

This clinical trial is studying a medication called ADI-PEG 20 to see how well it works and how safe it is for people with a liver condition known as Nonalcoholic Steatohepatitis (NASH). NASH is a ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tainan, , Taiwan, Taoyuan, , Taiwan +8 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions